Antibodies against the proliferating cell nuclear antigen (PCNA) was first discovered in the sera of systemic lupus erythematosus (SLE) patients. However, the reactivity and specificity of anti-PCNA autoantibodies are still unclear. To investigate the property of anti-PCNA autoantibodies, we conducted an ELISA screening of the anti-PCNA autoantibodies in sera of SLE patients. Eighteen out of 191 SLE sera were found to be positive for anti-PCNA antibodies giving a frequency of nearly 10%. Among the positive sera, a sample with the highest titer of anti-PCNA autoantibody preferentially recognizes the wild-type PCNA as compared to the Y114A mutation which contains a single amino acid substitution at 114 and fails to form the toroidal structure. Moreover, the autoantibody purified from this serum identifies only the free PCNA in crude mammalian cell extracts but not other associated cellular components. This finding raises a possibility that immunostaining with the human anti-PCNA autoantibodies in previous studies might have only partially PCNAs in tissues.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4077/cjp.2010.amh087 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Antinuclear antibody (ANA) positivity pattern by line immunoassay in a hospital from eastern India: Update from a laboratory perspective.
J Family Med Prim Care
April 2024
Department of Biochemistry, AIIMS Patna, Patna, Bihar, India.
Context: The existence of more than one antibody in systemic autoimmune rheumatic diseases (SARDs) or connective tissue disease (CTD) along with features of more than one autoimmune disease (AD) in an individual is suggestive of overlap syndrome (OS). Line immunoassay (LIA) can target many autoantibodies in a single approach, thus making the identification of OS feasible.
Aims And Objectives: This study aimed to identify the pattern of distribution of antinuclear antibodies by LIA prevalent in a hospital population in eastern India and identify common forms of SARD in this belt based on laboratory findings.
Combination of an Autoantibody Panel and Alpha-Fetoprotein for Early Detection of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Cancer Prev Res (Phila)
May 2024
College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.
Article Synopsis
- The study aimed to find biomarkers for hepatitis B virus-associated hepatocellular carcinoma (HBV-HCC) and created a new diagnostic panel with improved accuracy.
- Four candidate tumor-associated autoantibodies (anti-ZIC2, anti-CDC37L1, anti-DUSP6, and anti-PCNA) were identified and validated through various testing phases, with some showing better performance than the commonly used alpha-fetoprotein (AFP).
- The final diagnostic panel that included three of these autoantibodies demonstrated a higher detection rate for early HBV-HCC, especially in AFP-negative cases, suggesting it could complement existing diagnostic methods for more accurate identification of the disease.
Anti-DFS70 antibodies in systemic lupus erythematosus: Prevalence in a large Chinese cohort and an unexpected association with anti-dsDNA antibodies by a long-term follow-up.
Front Immunol
October 2022
Department of Laboratory Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Objective: Monospecific autoantibodies to dense fine speckles 70 (DFS70) antigen are purported to aid in excluding systemic autoimmune rheumatic diseases (SARD) such as systemic lupus erythematosus (SLE). However, the non-isolated anti-DFS70 still has a certain prevalence in SLE patients, and the clinical significance remains unclear. We aimed to investigate the prevalence, clinical relevance, and value of long-term monitoring of anti-DFS70 antibodies in SLE patients.
View Article and Find Full Text PDFEvidence of a distinct group of Black African patients with systemic lupus erythematosus.
BMJ Glob Health
September 2018
TIBA Partnership, NIHR Global Health Research Unit Tackling Infections to Benefit Africa (TIBA), University of Edinburgh, Edinburgh, UK.
Article Synopsis
- Systemic lupus erythematosus (SLE) is an autoimmune disease that affects mainly individuals of African descent, with current diagnostic criteria inadequately reflecting their specific patterns of disease presentation.
- The study analyzed serum samples from 61 Black African SLE patients and 100 controls, finding a much higher rate of detectable autoantibodies in SLE patients (97%) compared to controls (15%), with notable reactivities against dsDNA and PCNA.
- The research identified two distinct patient groups based on autoantibody profiles, suggesting that including anti-PCNA in diagnostics could improve the accuracy of SLE identification and understanding of its clinical manifestations in Black African populations.
Antinuclear antibody (ANA) testing is indispensable for diagnosing and understanding clinical conditions of autoimmune diseases. The indirect immunofluorescence assay (IFA) is the gold standard for ANA screening, and it can detect more than 100 different antibodies, such as anti-PCNA as well as anti-cytoplasmic antibodies. However, complicated procedures of conventional IFA and visual interpretation require highly skilled laboratory staff.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!